Loading data for EW — first visit, this takes a few seconds.
Edwards Lifesciences Corp... (EW)
NYSE: EW
· Real-Time Price · USD
90.87
+0.37 (0.41%)
At close: Aug 25, 2026, 8:00 PM
90.94
+0.08%
After-hours: 5:50 PM
The price, the headline numbers and the latest news, in one place.
Edwards Lifesciences Corporation (EW) Stock Price, Analysis & Data
0.41% (1D)
No data available
| Bid | 90.99 |
| Market Cap | 52.38B |
| Revenue (ttm) | 6.51B |
| Net Income (ttm) | 979.9M |
| 0.85 | |
| 1.68 | |
| 54.09 | |
| 26.9 | |
| P/B (ttm) | 4.93 |
| P/S (ttm) | 8.03 |
| Earnings Date | Oct 29, 2026 |
| Ask | 91 |
| Volume | 2,389,738 |
| Avg. Volume (20D) | 4,719,114 |
| Open | 90.38 |
| Previous Close | 90.50 |
| Day's Range | 89.68 - 91.26 |
| 52-Week Range | 72.30 - 96.29 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About EW
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the ...
Industry Medical Devices
Sector Healthcare
IPO Date Mar 27, 2000
Employees 16,000
Stock Exchange NYSE
Ticker Symbol EW
Website https://www.edwards.com
Financial Performance
In 2025, Edwards Lifesciences's revenue was 6.07B, an increase of 11.55% compared to the previous year's 5.44B. Earnings were 1.07B, a decrease of -74.28%.
Financial StatementsEarnings Surprise
Edwards Lifesciences has released their quarterly earnings on Jul 23, 2026:
- Revenue of n/a misses estimates by $0, with -100.00% YoY decline.
- EPS of 0.78 exceeds estimates by 0.04, with 16.42% YoY growth.
Edwards Lifesciences Corporation is scheduled to release its earnings on Oct 29, 2026, after market closes.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
Page 1 of 2